ArticleEnvironmental science and pollution research international2015
Prevalence and characteristics of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae isolated from rural well water in Taian, China, 2014.
Article in Environmental science and pollution research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 23 citations in OpenAlex.
- Shiga Toxin-ProducingVeterinary sciences · 2026Review
- Multidrug-Resistant and Potentially PathogenicFoods (Basel, Switzerland) · 2026Article
- Genetic Characterization, Transmission Pattern and Health Risk Analysis of Intestinal Colonization ESBL-ProducingMicroorganisms · 2024Article
- Current epidemiologic features and health dynamics of ESBL-producingBiosafety and health · 2024Review
- NDM-5-carrying3 Biotech · 2023Article
- Comparison of approaches for source attribution of ESBL-producing Escherichia coli in Germany.PloS one · 2022Article
- In Silico Analysis of Extended-Spectrum β-Lactamases in Bacteria.Antibiotics (Basel, Switzerland) · 2021Article
- Characterization of Clinically Relevant Strains of Extended-Spectrum β-Lactamase-ProducingFrontiers in microbiology · 2019Article
- ESBL-producingFood safety (Tokyo, Japan) · 2017Review
- Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level.Journal of travel medicine · 2017Review
- Article
- Global Escherichia coli Sequence Type 131 Clade with blaEmerging infectious diseases · 2016Article
- Comparison of Extended-SpectrumBioMed research international · 2016Article
- Enterobacteriaceae Isolated from the River Danube: Antibiotic Resistances, with a Focus on the Presence of ESBL and Carbapenemases.PloS one · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The production of extended-spectrum beta-lactamase (ESBL) is one of the major antimicrobial resistance mechanisms in Enterobacteriaceae, and the increasing number of ESBL-producing Enterobacteriaceae isolated from water environments has posed a serious threat to the public health. The study aimed to analyze prevalence and characterization of ESBL-producing Enterobacteriaceae from rural well waters in Taian, China. A total of 10 isolates expressing an ESBL phenotype, including 9 Escherichia coli (E. coli) and 1 Klebsiella pneumoniae (K. pneumoniae) was obtained from 4 (4%) out of the 100 sampled wells. ESBL genotype revealed that 9 expressed CTX-M-15 and 1 produced CTX-M-27. Five out of 8 ESBL-producing E. coli expressing CTX-M-15 belonged to ST10, which are mostly detected from human feces in China. Importantly, the only strain of CTX-M-27-producing E. coli belonged to multi-locus sequence type B2:131 (ST131), which may be related with severe infection in humans and animals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.